Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02114814 · ClinicalTrials.gov registry record · NA
A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
NCT02114814: Completed NA study, sponsored by Ohio State University.
NCT02114814 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 186 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02114814, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
Study Summary
The aim of this study was to compare the efficacy of an intervention and an attention control group in producing changes in diabetes self-management, glycemic control (HbA1c) and health related quality of life in Hispanics with type 2 diabetes. Hypothesis: The experimental group who receive an 8 week intervention program would show significantly greater improvements than an attention control group at 1 and 6 months after the intervention in: behavioral influences of diabetes knowledge, diabetes self-efficacy, and family support, outcomes of self-reported management of diabetes (physical activity, diet, medications, and glucose monitoring), HbA1c levels, and psychological outcomes of health-related quality of life.
Primary Outcome
Glycemic control in %.
Interventions
- BEHAVIORAL Diabetes self-management program for Hispanics and their families
- BEHAVIORAL General health educational program for Hispanics and their families
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-04 |
| Phase | NA |
What the finished NCT02114814 record still lists
NCT02114814 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Diabetes self-management program for Hispanics and their families is the first listed.
NCT02114814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02114814 about?
NCT02114814 is a clinical study titled "A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community". The aim of this study was to compare the efficacy of an intervention and an attention control group in producing changes in diabetes self-management, glycemic control (HbA1c) and health related quality of life in Hispanics with type 2 diabetes. Hypothesis: The experimental group who receive an 8 we...
What is the current status of trial NCT02114814?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2012-06. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02114814?
The interventions under investigation include: Diabetes self-management program for Hispanics and their families (BEHAVIORAL), General health educational program for Hispanics and their families (BEHAVIORAL).
Who is sponsoring clinical trial NCT02114814?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02114814's enrollment target sits among peer trials
186 579th of 2000 higher than 1,421 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia